| Revenue | SEK -1 | — |
| EBITDA | SEK -29K | +38% |
| Net profit | SEK -29K | +38% |
| Total assets | SEK 7K | -67% |
| Equity | SEK -59K | -94% |
| Employees | 0 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 120 | 0 | 0 | −0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −63 | −83 | −187 | −46 | −29 |
| Depreciation & amort. | −6 | −6 | −0 | — | — |
| EBIT | −69 | −89 | −187 | −46 | −29 |
| Net financials | — | — | — | 0 | 0 |
| Profit before tax | −69 | −89 | −187 | −46 | −29 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | −69 | −89 | −187 | −46 | −29 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 419 | 343 | 45 | 21 | 7 |
| Equity | 292 | 203 | 16 | −30 | −59 |
| Long-term debt | 0 | 0 | 0 | — | 10 |
| Short-term debt | 127 | 139 | 29 | 51 | 56 |
| Total debt | 127 | 139 | 29 | 51 | 66 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AH Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
No shareholder data available.
| Person | Role here | Other companies |
|---|---|---|
| Akoo Hematbolland | Chief Executive Officer | 0 companies |
| Karl-Johan Klasson von Heland | Deputy Board Member | 0 companies |